Real-world economic burden of disease recurrence in patients with muscle-invasive bladder cancer: A population-level claims-based analysis.

Saved in:
Bibliographic Details
Title: Real-world economic burden of disease recurrence in patients with muscle-invasive bladder cancer: A population-level claims-based analysis.
Authors: Squires P; Merck & Co., Inc., Rahway, NJ., Cook EE; Analysis Group, Inc., Boston, MA., Song Y; Analysis Group, Inc., Boston, MA., Wang CY; Merck & Co., Inc., Rahway, NJ., Jiang AX; Analysis Group, Inc., Boston, MA., Zhang A; Analysis Group, Inc., Boston, MA., Seshasayee SM; Analysis Group, Inc., Boston, MA., Rogiers A; Merck & Co., Inc., Rahway, NJ., Li H; Merck & Co., Inc., Rahway, NJ., Mamtani R; Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia.
Source: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2025 Dec; Vol. 31 (12), pp. 1248-1258. Date of Electronic Publication: 2025 Sep 17.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2376-1032 (Electronic) Linking ISSN: 23760540 NLM ISO Abbreviation: J Manag Care Spec Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2376-1032
DOI:10.18553/jmcp.2025.25106